We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$91.6M
Cap. Flow %
6.65%
Top 10 Hldgs %
28.56%
Holding
1,934
New
622
Increased
464
Reduced
326
Closed
465

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Communication Services 8.62%
3 Healthcare 8.45%
4 Financials 8.14%
5 Consumer Discretionary 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CY
376
DELISTED
Cypress Semiconductor
CY
$631K 0.05%
37,230
+29,430
+377% +$504K
VISN
377
Vistance Networks Inc
VISN
$2.52B
$629K 0.05%
15,736
+3,226
+26% +$126K
HSY icon
378
Hershey
HSY
$36.6B
$624K 0.05%
6,307
+954
+18% +$98.6K
INTU icon
379
Intuit
INTU
$89B
$624K 0.05%
3,600
+1,396
+63% +$235K
BW icon
380
Babcock & Wilcox
BW
$1.39B
$621K 0.05%
14,200
+7,700
+118% +$447K
HRL icon
381
Hormel Foods
HRL
$13.8B
$616K 0.04%
17,935
+4,008
+29% +$136K
WM icon
382
Waste Management
WM
$91B
$611K 0.04%
7,262
+3,007
+71% +$258K
GTT
383
DELISTED
GTT Communications, Inc.
GTT
$610K 0.04%
10,753
-5,027
-32% -$248K
SEDG icon
384
SolarEdge
SEDG
$1.95B
$605K 0.04%
11,510
+6,910
+150% +$303K
CA
385
DELISTED
CA, Inc.
CA
$598K 0.04%
17,630
+6,729
+62% +$234K
BIO icon
386
Bio-Rad Laboratories Class A
BIO
$9.42B
$596K 0.04%
2,383
-4,839
-67% -$1.23M
PBYI icon
387
Puma Biotechnology
PBYI
$454M
$594K 0.04%
8,723
-3,636
-29% -$272K
ZBRA icon
388
Zebra Technologies
ZBRA
$17.8B
$594K 0.04%
+4,270
New +$547K
CPRI icon
389
Capri Holdings
CPRI
$1.74B
$589K 0.04%
9,480
+2,502
+36% +$159K
AIV
390
Aimco
AIV
$383M
$587K 0.04%
+108,203
New +$580K
SRCL
391
DELISTED
Stericycle Inc
SRCL
$587K 0.04%
10,021
+2,331
+30% +$158K
VRSK icon
392
Verisk Analytics
VRSK
$25B
$584K 0.04%
+5,615
New +$560K
EVHC
393
DELISTED
Envision Healthcare Holdings Inc
EVHC
$580K 0.04%
15,087
-2,321
-13% -$86.7K
GWPH
394
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$579K 0.04%
5,143
+2,151
+72% +$270K
HALO icon
395
Halozyme
HALO
$12.2B
$578K 0.04%
29,482
+27,682
+1,538% +$536K
ZWS icon
396
Zurn Elkay Water Solutions
ZWS
$8.53B
$576K 0.04%
40,274
+25,775
+178% +$353K
DCT
397
DELISTED
DCT Industrial Trust Inc.
DCT
$575K 0.04%
10,200
-2,597
-20% -$147K
SRE icon
398
Sempra
SRE
$54.8B
$565K 0.04%
10,162
+2,846
+39% +$154K
FCX icon
399
Freeport-McMoran
FCX
$97.5B
$560K 0.04%
31,866
+1,331
+4% +$25K
WT icon
400
CALL
WisdomTree
WT
$3.22B
$558K 0.04%
60,800
+51,000
+520% +$551K

Similar funds

Prelude Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Prelude Capital Management held 1,934 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Prelude Capital Management deployed $91.6M of net new capital in Q1 2018, opening 622 new positions and adding to 464 existing holdings. Its largest new stake was XL Group Ltd.: 571,194 shares worth $31.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Twenty-First Century Fox, Inc. Class B, an estimated $10.5M trimmed.

  • Prelude Capital Management's largest Q1 2018 buy was XL Group Ltd.: 571,194 shares worth $31.6M.
  • Prelude Capital Management added most to NXP Semiconductors in Q1 2018, an estimated $19.7M increase.
  • Prelude Capital Management's biggest Q1 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $10.5M.
  • Prelude Capital Management fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $21.7M.
  • Prelude Capital Management's ten largest holdings make up 29% of its $1.38B portfolio in Q1 2018.
  • Prelude Capital Management opened 622 new positions and closed 465 in Q1 2018.
  • Prelude Capital Management's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Prelude Capital Management's 13F filing for Q1 2018, filed 15 May 2018.